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brief communications 
Synergistic effects of 
traumatic head injury 
and apolipoprotein-~4 
in patients with 
Alzheimer’s disease 
Article abstract-The apolipoprotein-~4 allele increases the  risk of 
Alzheimer’s disease (AD), but cerebral deposition of P-amyloid with age, a 
genetic mutation, or head injury may contribute to the pathogenesis of this 
disease. We examined the risks of AD associated with traumatic head injury 
and apolipoprotein-~4 in 236 community-dwelling elderly persons. A 10-fold 
increase in the risk of AD was associated with both apolipoprotein-~4 and a 
history of traumatic head injury, compared with a two-fold increase in risk 
with apolipoprotein-~4 alone. Head injury in the absence of an apolipopro- 
t e i n - ~ 4  allele did not increase risk. These data imply that  the biological 
effects of head injury may increase the risk of AD, but only through a syner- 
gistic relationship with apolipoprotein-~4. 
NEUROLOGY 1995;45:555-557 
R. Mayeux, MD; R. Ottman, PhD; G. Maestre, MD; C. Ngai, BS; M.-X. Tang, PhD; H. Ginsberg, MD; 
M. Chun, MD; B. Tycko, MD, PhD; and M. Shelanski, MD, PhD 
Roberts et all observed cerebral P-amyloid (PAP) 
deposits and neurofibrillary tangles in the brains of 
professional and amateur boxers who were dement- 
ed before death and in individuals who died as a 
result of severe head injury. Further, some but not 
all epidemiologic studies have found an  association 
between Alzheimer’s disease (AD) and head injury.2 
Roberts et all also found increased expression of p- 
amyloid precursor protein (PAPP) following trauma 
to the brain; this has been interpreted as an  acute 
response to neuronal injury. They considered these 
observations to be compatible with a major role for 
amyloid deposition in  t h e  pathogenesis of AD 
because cerebral PAP deposition is considered a 
key step in a “neurotoxic” cascade leading to neu- 
ritic plaques and neuronal death.3 
Because individuals homozygous or heterozy- 
gous for apolipoprotein-€4 (Ap0-d) are a t  signifi- 
cantly higher risk for AD than individuals with 
other  genotype^,^ and because the amount of cere- 
bral PAP deposition in AD may be related to the 
specific Apo-E g e n ~ t y p e , ~  we hypothesized that a 
history of traumatic head injury and the presence 
of an Ap0-d allele would have a synergistic effect 
on t h e  risk of AD among community-dwelling 
elderly people. 
Methods. Blood for genomic DNA testing was obtained 
from 113 patients meeting research criteria for AD and 
from 123 healthy elderly persons. Both groups of subjects 
resided in the same region of northern Manhattan and 
were identified in a population-based study of AD and 
related dementias. Eight of the 113 cases of AD were 
autopsy confirmed. Cases and controls were matched for 
age (within 5 years), gender, and ethnic group (African 
American, Hispanic, or white). 
Gnomic DNA was amplified by polymerase chain reac- 
tion, using reaction conditions modified from those 
described by Hixson and Vernier.6 The genotypes were 
determined by the sizes of DNA fragments present, viewed 
and photographed under ultraviolet light after staining 
with 0.5 pg/ml of ethidium bromide. All genotypes were 
determined without knowledge of patient-control status. 
Data collection. A semi-structured interview, previ- 
ously established as reliable, was used to inquire about 
head injury with loss of consciousness.2 For ethnic group 
classification, we used the format suggested by the 1990 
United States Census Bureau. 
Data analysis. Allele frequencies for patients with AD 
and controls were estimated by counting alleles and cal- 
culating sample proportions. Frequencies of Apo-E geno- 
types in patients and controls were compared using the 
chi-square test .  The frequencies for the  demographic 
variables (including ethnic group) and risk factors were 
compared between cases and controls using chi-square 
analyses. Both univariate and multivariate odds ratios 
for AD associated with Ap0-d were calculated from logis- 
tic regression adjusting for age and ethnic group. 
Results. Patients with AD and controls were simi- 
lar in age (AD 74.0 f 10.5 [SDI, controls 72.0 f 9.1 
[SD]),  gender  (% women: AD 74.5%, controls 
69.1%), and ethnic group (African American: AD 
50.7%, controls 49.3%; Hispanic: AD 48.9%, con- 
trols 51.1%; and white: AD 44%, controls 56%). AD 
patients had significantly fewer years of education 
than did controls (AD 8.5 * 5.6, controls 10.4 * 4.8; 
p < 0.01). 
The allele frequency of Apo-d was significantly 
greater among patients with AD than in controls 
(0.29 versus 0.16; x 2  = 13.4, p c 0.001). The Apo-€4 
allele frequency did not differ by age, gender, or 
years of education within either cases or controls. 
Apo-d  allele frequency was similar for patients 
wi th  AD regard less  of e t h n i c  group (African 
American 0.33, Hispanic 0.34, and white 0.30), but 
differed significantly among controls (African 
American 0.28, Hispanic 0.13, and white 0.10; x2 = 
11.2, p < 0.05). The odds ratio (OR) for AD associat- 
ed with homozygosity for Apo-€4 was 3.9 (95% CI, 
1.2 to 13.2, p c 0.01) and that associated with het- 
erozygosity was 2.0 (95% CI, 1.2 to 3.6, p c 0.01) 
compared with other Apo-E genotypes. Adjustments 
for age, education, and ethnic group did not result 
in a change in the magnitude of the OR for AD asso- 
ciated with Ap0-d homozygosity or heterozygosity. 
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Table. Independent effects of apolipoprotein-e4 (Ap0-E.Q) and head injury among patients and controls 
I 
Head Ap0-d Alzheimer's Adjusted for age and 
injury (one or more alleles) disease Controls Odds ratio (95% CI)* education (95% CI)* 
No 
No 
Yes 
Yes 
No 
Yes 
No 
Yes 
52 78 1.0, reference 1.0, reference 
48 35 2.0 (1.2-3.6)T 2.0 (l.l-3.5)t 
6 9 1.0 (0.3-2.9) 1.0 (0.3-3.2) 
7 1 10.5 (1.3-88.7)t 10.2 (1.2-89.0)t 
* 95% confidence interval for the odds ratio. In this stratified analysis, we had 80% power to detect an odds ratio of 9.6 or more for the interaction. 
? Statistical  significance,^ < 0.05. 
Thirteen patients (11.5%) with AD had a history 
of head trauma associated with loss of conscious- 
ness that preceded onset of dementia by at least 2 
years, whereas 10 (8.1%) controls reported a simi- 
lar injury. The distribution of head injury was simi- 
lar across ethnic groups. The OR for AD associated 
with head injury was 1.5 (95% CI, 0.5 to 3.5, p = 
0.5). To examine the relationship between the pres- 
ence of Ap0-d and head injury in terms of their 
joint and independent effects on the risk of AD, we 
stratified the cases and controls by these two vari- 
ables (table). There was no difference in age, gen- 
der, or ethnic group among the cases and controls 
across the four strata. Using as the reference group 
persons with neither a history of head injury nor 
an Apo-€4 allele, we estimated the OR for AD asso- 
ciated with both a history of traumatic head injury 
and the presence of at least one Apo-€4 allele (OR = 
10.5; 95% CI, 1.3 to  87.81, traumatic head injury 
alone (OR = 1.0; 95% CI, 0.3 to 2.91, and the pres- 
ence of Apo-€4 alone (OR = 2.0; 95% CI, 1.1 to 3.51, 
adjusting for age by logistic regression. Thus, the 
OR for the joint effect of head injury and Apo-€4 
exceeded tha t  expected from the independent 
effects of both risk factors (ie, 1.0 x 2.0 = 2.01, sug- 
gesting a synergistic relationship. We also formally 
tested for interaction using logistic regression. In 
this model, the OR for Apo-€4 was 2.1 (95% CI, 1.2 
to 3.6, p c 0.011, that for head injury was 1.0 (95% 
CI, 0.3 to 3.1, p = l .O), and that for the interaction 
(ie, Apo-~4*head injury) was 5.1 (95% CI, 0.6 t o  
43.8, p = 0.1). 
Discussion. This investigation provides evidence 
to suggest a synergistic relationship between an 
environmental risk factor (head injury) and a 
marker of genetic susceptibility to AD (Ap0-d). 
Although the number of patients and controls with 
head injury we report is modest, the frequency of 
this risk factor approximates the lifetime frequency 
we observed in  a previous s tudy in this  
community.2 In the absence of Apo-€4, the OR for 
head injury was not elevated; thus, our results 
indicate that the effect of head injury on AD risk 
may be restricted to persons either homozygous or 
heterozygous for Apo-€4. The findings are most con- 
sistent with a model in which an environmental 
risk factor has no effect alone, yet it exacerbates 
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the effect of genetic sus~ept ib i l i ty .~  The OR for 
interaction using logistic regression was elevated; 
however, it  was not statistically significant, but 
this analysis was very conservative. To detect a sig- 
nificant interaction of the same magnitude using 
this approach we would need nearly twice as many 
subjects.8 As such, our conclusions must remain 
tentative, but they are consistent with two major 
views on the pathogenesis of AD. 
The pathology of dementia in boxers was consid- 
ered to consist mostly of neurofibrillary tangle for- 
mation, but Roberts et al,l using immunostaining, 
identified PAP deposits in brain as well. Moreover, 
they also detected diffuse deposits of PAP, not neu- 
rofibrillary tangles, in the upper layers of the neo- 
cortex of patients with fatal head injuries but no 
history of dementia, as well as  increased PAPP 
immunoreactivity in all head-injury cases exam- 
ined.' The latter observation might suggest that  
PAPP is increased as an acute-phase response to  
neuronal injury, which, in turn, leads to PAP depo- 
sition in cortex. The amyloid hypothesis converges 
on the role of cerebral PAP deposition as the initial 
event leading to the formation of neuritic plaques 
and subsequent neuronal death. PAP deposition 
may result in cell death by binding t o  specific 
molecules on the cell surface or by rendering neu- 
rons more susceptible to excitotoxic, ischemic, or 
other metabolic  constituent^.^ Because Apo-E is 
involved in cholesterol transport, it  may sequester 
proteins such as  amyloid in response t o  brain 
i n j ~ r y . ~  Poirier et a19 found Apo-E mRNA and the 
number of Apo-E immunoreactive cells increased 
following electrolytic lesions of rat hippocampus, 
and proposed that Apo-E could be a trophic factor 
secreted by astrocytes for membrane synthesis and 
synaptogenesis in response to injury. Thus, individ- 
uals with one or more copies of the Apo-€4 allele 
might be more likely to deposit PAP in cortex fol- 
lowing head injury than individuals with other 
genotypes. 
Our results would also be compatible with a 
recent hypothesis forwarded by Strittmatter et al, lo 
who proposed that the absence of Apo-€3 results in 
more rapid tau phosphorylation, leading to insta- 
bility of the microtubule system in neurons and the 
formation of paired helical filaments and neurofib- 
rillary tangles, thereby increasing the risk of AD. 
Thus. the formation of neurofibrillarv tangles in References 
Y 
people with a history of head injury kho  become 
demented might be related to their Apo-E genotype 
as well to any direct effect of the trauma. 
The exact mechanism underlying the role of Apo- 
E in the pathogenesis of AD remains unresolved, 
but the Apo-E genotype may specify a degree of 
genetic susceptibility to  AD that can be exacerbat- 
ed by the effects of other genes or environmental 
risk factors such as traumatic head injury. 
Acknowledgments 
The authors thank Drs. Steven Albert, Nicole Schupf, and 
Karen Marder for their critical review of the manuscript. 
~ ~~ ~ 
From the Gertrude H. Sergievsky Center (Drs. Mayeux, Ottman, and 
Tang), the Division of Epidemiology, School of Public Health (Drs. 
Mayeux and Ottman), the Center for Alzheimer’s Disease Research in the 
City of New York (Drs. Mayeux, Maestre, Tycko, and Shelanski), and the 
Departments of Neurology (Drs. Mayeux, Tang, and Chun), Psychiatry 
(Dr. Mayeux), Pathology (Drs. Maestre, Tycko, and Shelanski), and 
Medicine (C. Ngai and Dr. Ginsberg), Columbia University, and the 
Epidemiology of Brain Disorders Research Department of the New York 
State Psychiatric Institute (Dr. Ottman), New York, NY. 
Supported by the following federal grants: AG07232, AG10963, AG08702, 
HL36000, HL21007, and RR00645 and from the Charles S. Robertson 
Memorial Gift for Alzheimer’s Disease Research from the Banbury Fund. 
Received June 27, 1994. Accepted in final form August 29, 1994. 
Address correspondence and reprint requests to Dr. R. Mayeux, G.H. 
Sergievsky Center, 630 West 168th Street, Columbia University, New 
York, NY 10032. 
1. Roberts GW, Gentleman SM, Lynch A, et al. P-Amyloid pro- 
tein deposition in  the brain after severe head injury. J 
Neurol Neurosurg Psychiatry 1994;57:419-425. 
2. Mayeux R, Ottman R, Tang M-X, et al. Genetic susceptibili- 
ty and head injury as  risk factors for Alzheimer’s disease 
among community-dwelling elderly persons and their first- 
degree relatives. Ann Neurol 1993;33:494-501. 
3. Selkoe DJ. Physiological production of the amyloid P-amy- 
loid protein and the mechanism of Alzheimer’s disease. 
Trends Neurosci 1993;16:403-409. 
4. Saunders  AM, S t r i t t m a t t e r  WJ,  Schmechel D, e t  a l .  
Association of apolipoprotein E allele €4 with late-onset 
familial and  sporadic Alzheimer’s disease. Neurology 
5. S t r i t t m a t t e r  WJ,  S a u n d e r s  AM, Schmechel D, e t  a l .  
Apolipoprotein E: High affinity binding to beta-amyloid and 
increased frequency of type 4 allele in late onset familial 
Alzheimer’s disease. Proc Natl Acad Sci USA 1993;90:1977- 
1981. 
6. Hixson J ,  Vernier D. Restriction isotyping of human 
apolipoprotein E by gene amplification and cleavage with 
HhAl. J Lipid Res 1991;31:545-548. 
7. Ottman R. An epidemiologic approach to gene-environment 
interaction. Genet Epidemiol 1990;7: 177-185. 
8. Smith PG, Day NE. The design of case-control studies: the 
influence of confounding and interaction effects. Int  J 
Epidemiol 1984;13:356-365. 
9. Poirier J ,  Hess M, May PC, Finch CE. Cloning of hippocam- 
pal poly(A) RNA sequences that increase after entorhinal 
cortex lesion i n  a d u l t  r a t .  Brain Res Mol Brain Res 
10. S t r i t t m a t t e r  WJ,  Weisgraber  KH, Goedert  M, e t  a l .  
Hypothesis: microtubule instability and paired helical fila- 
ment formation in the Alzheimer disease brain are related 
to apolipoprotein E genotype. Exp Neurol 1994;125:163-171. 
1993;43:1467-1472. 
1991;9:191-195. 
Sneddon’s syndrome 
is a thrombotic 
vasculopathy: 
Neuropathologic and 
neuroradiologic 
evidence 
Article abstract-We report the first case of pathologic findings from 
brain biopsy in a patient with Sneddon’s syndrome. The observations sug- 
gest that Sneddon’s syndrome is not a vasculitis but is more comparable to 
the autoimmune vasculopathies such as the antiphospholipid antibody syn- 
drome. Vascular thrombosis and emboli from cardiac sources are the likely 
causes of stroke in most cases. The success of warfarin in the treatment of 
antiphospholipid syndromes and the failure of immunosuppression and 
aspirin in the treatment of Sneddon’s syndrome argue that warfarin antico- 
agulation may be the most appropriate intervention currently available. 
NEUROLOGY 1995;45:557-560 
Daniel H. Geschwind, MD, PhD; Michael FitzPatrick, MD, MS; 
Paul S. Mischel, MD; and Jeffrey L. Cummings, MD 
Sneddon’s syndrome is the association of cerebral 
vascular disease and livedo reticularis (racemosa). 
Its prevalence and its etiology are ~ n k n o w n . ~  The 
average time to diagnosis of Sneddon’s syndrome is 
10 years from the onset of symptoms, and it is likely 
an underdiagnosed ~ondition.~ Although some stud- 
ies have reported that up to 35% of patients with 
this syndrome test positive for antiphospholipid 
antib~dies,~ most test nega t i~e .~ .~ .~ , .“  Reports of der- 
matologic pathology have been conflicting; while 
some have revealed vasculitic features including 
small-vessel endothelitis and inflammatory obstruc- 
tion,”.“ others describe a noninflammatory vascu- 
lopathy restricted to small and medium-sized arter- 
i e ~ . ~ ? ~  The brain pathology has been inferred from 
MRI and CT studies; no brain biopsies and only one 
limited autopsy specimen have been r e p ~ r t e d . ~ . ~  In 
addition, only a few reports2-6s8 have included angio- 
graphic or single-photon emission computerized 
tomographic (SPECT) studies. 
We report the unusual case of a young woman 
with a progressive vascular dementia due to 
Sneddon’s syndrome and discuss the results of her 
clinical and laboratory evaluation, including cere- 
bral angiography, in the context of the histopatho- 
logic findings in her brain biopsy. 
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